Platelet-activating factor in bronchoalveolar lavage fluid from asthmatic subjects

SC Stenton, WP Kingston, P Goadby… - European …, 1990 - Eur Respiratory Soc
SC Stenton, WP Kingston, P Goadby, CA Kelly, M Duddridge, C Ward, DJ Hendrick…
European Respiratory Journal, 1990Eur Respiratory Soc
Bronchoalveolar lavage (BAL) was performed on 28 asthma patients, 7 patients with
emphysema and 11 control subjects. Total and differential cell counts were performed and
cellular metabolic activity was assessed using luminol and lucigenin amplified
chemiluminescence. BAL supernatants were assayed for platelet-activating factor (PAF) and
lyso-PAF using a sensitive guinea-pig bioassay. Eight of the asthma patients but none of the
emphysema patients or control subjects had PAF in their BAL fluid. Lyso-PAF was …
Bronchoalveolar lavage (BAL) was performed on 28 asthma patients, 7 patients with emphysema and 11 control subjects. Total and differential cell counts were performed and cellular metabolic activity was assessed using luminol and lucigenin amplified chemiluminescence. BAL supernatants were assayed for platelet-activating factor (PAF) and lyso-PAF using a sensitive guinea-pig bioassay. Eight of the asthma patients but none of the emphysema patients or control subjects had PAF in their BAL fluid. Lyso-PAF was measurable in BAL fluid in most subjects and no differences were detected between groups. Among the asthma patients, the presence of PAF in BAL supernatant was significantly associated with a combination of low neutrophil and high lymphocyte counts (p less than 0.05) and with macrophage metabolic activity as assessed by lucigenin chemiluminescence (p less than 0.05).
European Respiratory Society